Sipho Mdanda

450 total citations
31 papers, 313 citations indexed

About

Sipho Mdanda is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Virology. According to data from OpenAlex, Sipho Mdanda has authored 31 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Virology. Recurrent topics in Sipho Mdanda's work include Radiopharmaceutical Chemistry and Applications (6 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (5 papers). Sipho Mdanda is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (5 papers). Sipho Mdanda collaborates with scholars based in South Africa, United States and Jordan. Sipho Mdanda's co-authors include Pierre P. D. Kondiah, Yahya E. Choonara, Tricia Naicker, Hendrik G. Kruger, Thavendran Govender, Sooraj Baijnath, Pradeep Kumar, Philemon Ubanako, Sanil D. Singh and Mike Sathekge and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and RSC Advances.

In The Last Decade

Sipho Mdanda

29 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sipho Mdanda South Africa 10 101 63 55 44 39 31 313
Priyanka Arora United States 8 457 4.5× 119 1.9× 29 0.5× 41 0.9× 13 0.3× 15 696
Nidhi Nainwal India 10 165 1.6× 78 1.2× 12 0.2× 36 0.8× 11 0.3× 41 372
Ashlee D. Brunaugh United States 12 166 1.6× 113 1.8× 48 0.9× 15 0.3× 3 0.1× 16 420
Valentine Wascotte Belgium 8 149 1.5× 109 1.7× 10 0.2× 36 0.8× 5 0.1× 12 365
Zachary N. Warnken United States 13 232 2.3× 136 2.2× 77 1.4× 7 0.2× 3 0.1× 19 494
Kurtis Moffatt United Kingdom 10 560 5.5× 104 1.7× 40 0.7× 250 5.7× 39 1.0× 13 695
Sujata Sawarkar India 12 111 1.1× 74 1.2× 18 0.3× 15 0.3× 4 0.1× 33 354
Rohan Pai India 10 220 2.2× 112 1.8× 31 0.6× 3 0.1× 41 1.1× 18 391
Abd-Elhameed EL-Shamy Egypt 7 255 2.5× 71 1.1× 7 0.1× 63 1.4× 2 0.1× 10 383
Alan Smith United States 7 64 0.6× 86 1.4× 34 0.6× 5 0.1× 21 0.5× 10 320

Countries citing papers authored by Sipho Mdanda

Since Specialization
Citations

This map shows the geographic impact of Sipho Mdanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sipho Mdanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sipho Mdanda more than expected).

Fields of papers citing papers by Sipho Mdanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sipho Mdanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sipho Mdanda. The network helps show where Sipho Mdanda may publish in the future.

Co-authorship network of co-authors of Sipho Mdanda

This figure shows the co-authorship network connecting the top 25 collaborators of Sipho Mdanda. A scholar is included among the top collaborators of Sipho Mdanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sipho Mdanda. Sipho Mdanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ndlovu, Honest, Ismaheel O. Lawal, Sipho Mdanda, et al.. (2025). Targeted alpha therapy in prostate cancer: review of available agents in clinical practice. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 69(2). 118–128.
3.
Ndlovu, Honest, Ismaheel O. Lawal, Kgomotso Mokoala, Sipho Mdanda, & Mike Sathekge. (2025). New Promising Targets for Imaging in Infection. Seminars in Nuclear Medicine. 55(5). 804–811. 1 indexed citations
4.
Mdanda, Sipho, et al.. (2025). Advances in Dosimetry and Imaging for 203Pb and 212Pb Radiotheranostics. Seminars in Nuclear Medicine. 55(6). 1011–1031. 1 indexed citations
5.
Ndlovu, Honest, Sipho Mdanda, Akram Al‐Ibraheem, et al.. (2025). Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier. Seminars in Nuclear Medicine. 55(6). 912–927. 2 indexed citations
6.
Ndlovu, Honest, Ismaheel O. Lawal, Sipho Mdanda, et al.. (2024). [18F]F-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology. Journal of Clinical Medicine. 13(12). 3426–3426. 4 indexed citations
7.
Ndlovu, Honest, et al.. (2024). Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium. SHILAP Revista de lepidopterología. 4. 1355912–1355912. 4 indexed citations
8.
Welling, Mick M., Honest Ndlovu, Sipho Mdanda, et al.. (2024). Insights into Peptidoglycan-Targeting Radiotracers for Imaging Bacterial Infections: Updates, Challenges, and Future Perspectives. ACS Infectious Diseases. 10(2). 270–286. 4 indexed citations
9.
Mahapane, Johncy, et al.. (2024). Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment. SHILAP Revista de lepidopterología. 4. 1469897–1469897. 2 indexed citations
11.
Peters, Byron K., Sooraj Baijnath, Sipho Mdanda, et al.. (2023). Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors. Antibiotics. 12(4). 633–633. 3 indexed citations
12.
Peters, Byron K., Sooraj Baijnath, Sipho Mdanda, et al.. (2023). In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales. ACS Infectious Diseases. 9(3). 486–496. 8 indexed citations
13.
Mdanda, Sipho, et al.. (2023). Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review. Pharmaceutics. 15(6). 1719–1719. 7 indexed citations
14.
Mdanda, Sipho, Sanil D. Singh, Tricia Naicker, et al.. (2019). Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder. Assay and Drug Development Technologies. 17(7). 322–329. 3 indexed citations
15.
Mdanda, Sipho, Sanil D. Singh, Tricia Naicker, et al.. (2019). Mass Spectrometry Imaging Demonstrates the Regional Brain Distribution Patterns of Three First-Line Antiretroviral Drugs. ACS Omega. 4(25). 21169–21177. 23 indexed citations
16.
Mdanda, Sipho, et al.. (2019). Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND). Journal of Molecular Histology. 50(4). 295–303. 10 indexed citations
17.
Mdanda, Sipho, Tricia Naicker, Hendrik G. Kruger, et al.. (2019). Brain penetration of ketamine: Intranasal delivery VS parenteral routes of administraion. Journal of Psychiatric Research. 112. 7–11. 15 indexed citations
19.
Mdanda, Sipho, Sanil D. Singh, Tricia Naicker, et al.. (2019). Investigating time dependent brain distribution of nevirapine via mass spectrometric imaging. Journal of Molecular Histology. 50(6). 593–599. 4 indexed citations
20.
Mdanda, Sipho, Sooraj Baijnath, Adeola Shobo, et al.. (2017). Lansoprazole‐sulfide, pharmacokinetics of this promising anti‐tuberculous agent. Biomedical Chromatography. 31(12). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026